Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Magnetic Resonance Spectroscopy | 35 | 2018 | 3782 | 2.950 |
Why?
|
Pseudomonas aeruginosa | 9 | 2024 | 1276 | 1.730 |
Why?
|
Muscle, Skeletal | 17 | 2024 | 4978 | 1.610 |
Why?
|
Pseudomonas Infections | 8 | 2024 | 623 | 1.320 |
Why?
|
Burns | 10 | 2013 | 1901 | 1.270 |
Why?
|
Brain Neoplasms | 20 | 2016 | 9213 | 1.020 |
Why?
|
Acetophenones | 3 | 2024 | 52 | 1.020 |
Why?
|
Robotics | 5 | 2019 | 826 | 0.990 |
Why?
|
Quorum Sensing | 6 | 2024 | 137 | 0.840 |
Why?
|
Adenosine Triphosphate | 8 | 2024 | 2003 | 0.820 |
Why?
|
Magnetic Resonance Imaging | 24 | 2023 | 36854 | 0.800 |
Why?
|
Mitochondria | 11 | 2024 | 3682 | 0.780 |
Why?
|
Drosophila melanogaster | 4 | 2015 | 1726 | 0.670 |
Why?
|
Ion Channels | 3 | 2015 | 1043 | 0.610 |
Why?
|
Mitochondrial Proteins | 3 | 2015 | 980 | 0.570 |
Why?
|
Volatile Organic Compounds | 1 | 2018 | 86 | 0.560 |
Why?
|
Insulin Resistance | 4 | 2015 | 3982 | 0.560 |
Why?
|
Hand Strength | 2 | 2019 | 466 | 0.550 |
Why?
|
Lipid Metabolism | 9 | 2010 | 1904 | 0.510 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 2 | 2009 | 508 | 0.500 |
Why?
|
Citric Acid Cycle | 2 | 2013 | 234 | 0.490 |
Why?
|
Contrast Media | 4 | 2018 | 5334 | 0.480 |
Why?
|
Neuronal Plasticity | 3 | 2013 | 1448 | 0.470 |
Why?
|
Stroke | 5 | 2023 | 9756 | 0.450 |
Why?
|
Mitochondria, Muscle | 2 | 2024 | 172 | 0.440 |
Why?
|
Cerebrovascular Disorders | 2 | 2019 | 1486 | 0.430 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 2067 | 0.420 |
Why?
|
Thoracic Injuries | 1 | 2015 | 288 | 0.420 |
Why?
|
Drosophila Proteins | 2 | 2014 | 1712 | 0.420 |
Why?
|
Cachexia | 2 | 2013 | 202 | 0.410 |
Why?
|
Oligopeptides | 3 | 2024 | 1194 | 0.410 |
Why?
|
Glutathione Transferase | 1 | 2014 | 564 | 0.390 |
Why?
|
Apoptosis | 5 | 2016 | 9527 | 0.350 |
Why?
|
Wounds and Injuries | 2 | 2015 | 2517 | 0.350 |
Why?
|
Gene Expression Profiling | 8 | 2012 | 9549 | 0.350 |
Why?
|
Mitochondrial Diseases | 1 | 2013 | 344 | 0.330 |
Why?
|
Magnetite Nanoparticles | 1 | 2010 | 313 | 0.320 |
Why?
|
Dextrans | 1 | 2010 | 574 | 0.310 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2009 | 3810 | 0.310 |
Why?
|
Wound Infection | 1 | 2010 | 243 | 0.300 |
Why?
|
Aspartic Acid | 5 | 2004 | 577 | 0.300 |
Why?
|
Image Enhancement | 1 | 2018 | 2898 | 0.300 |
Why?
|
Glycine | 2 | 2010 | 672 | 0.290 |
Why?
|
Oxidative Stress | 2 | 2016 | 3139 | 0.280 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1469 | 0.280 |
Why?
|
Antioxidants | 2 | 2019 | 1673 | 0.260 |
Why?
|
Lipids | 4 | 2014 | 3345 | 0.240 |
Why?
|
Electron Spin Resonance Spectroscopy | 2 | 2015 | 161 | 0.230 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2008 | 1495 | 0.230 |
Why?
|
Choline | 8 | 2004 | 522 | 0.230 |
Why?
|
Energy Metabolism | 2 | 2024 | 2905 | 0.220 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2018 | 9080 | 0.220 |
Why?
|
Protons | 5 | 2008 | 1113 | 0.210 |
Why?
|
Genomics | 2 | 2010 | 5928 | 0.210 |
Why?
|
Macrophages | 2 | 2024 | 5801 | 0.210 |
Why?
|
Mice | 18 | 2024 | 82072 | 0.210 |
Why?
|
Paresis | 1 | 2023 | 177 | 0.200 |
Why?
|
Brain | 11 | 2013 | 27453 | 0.190 |
Why?
|
Animals | 23 | 2024 | 169335 | 0.190 |
Why?
|
Asphyxia Neonatorum | 1 | 2002 | 111 | 0.190 |
Why?
|
Trans-Activators | 2 | 2008 | 2858 | 0.190 |
Why?
|
Hindlimb | 4 | 2008 | 516 | 0.190 |
Why?
|
Gadolinium DTPA | 2 | 2002 | 823 | 0.180 |
Why?
|
Hand | 3 | 2019 | 913 | 0.180 |
Why?
|
Biopsy | 6 | 2016 | 6805 | 0.180 |
Why?
|
Artificial Intelligence | 2 | 2012 | 2666 | 0.180 |
Why?
|
Down-Regulation | 1 | 2008 | 2942 | 0.180 |
Why?
|
Blood Volume | 1 | 2002 | 546 | 0.180 |
Why?
|
Lactic Acid | 3 | 2004 | 1140 | 0.170 |
Why?
|
Central Nervous System Neoplasms | 2 | 2007 | 930 | 0.170 |
Why?
|
Insulin | 2 | 2014 | 6610 | 0.170 |
Why?
|
Glioblastoma | 3 | 2012 | 3525 | 0.170 |
Why?
|
Cerebrovascular Circulation | 2 | 2002 | 2734 | 0.170 |
Why?
|
Oxidative Phosphorylation | 3 | 2024 | 501 | 0.160 |
Why?
|
Magnetic Resonance Angiography | 2 | 2004 | 1434 | 0.160 |
Why?
|
Neoplasm Metastasis | 1 | 2010 | 4926 | 0.160 |
Why?
|
Motor Activity | 1 | 2009 | 2713 | 0.160 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2012 | 8664 | 0.150 |
Why?
|
Mice, Inbred Strains | 3 | 2010 | 1769 | 0.150 |
Why?
|
Brain Chemistry | 4 | 2004 | 959 | 0.140 |
Why?
|
Body Surface Area | 2 | 2008 | 206 | 0.140 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2010 | 558 | 0.140 |
Why?
|
Speech Perception | 1 | 2002 | 512 | 0.140 |
Why?
|
Spin Labels | 2 | 2008 | 339 | 0.140 |
Why?
|
Aging | 1 | 2015 | 8745 | 0.130 |
Why?
|
Carbohydrate Metabolism | 2 | 2009 | 262 | 0.130 |
Why?
|
Humans | 42 | 2024 | 768970 | 0.130 |
Why?
|
Reactive Oxygen Species | 3 | 2024 | 2149 | 0.130 |
Why?
|
Arousal | 1 | 2002 | 1183 | 0.130 |
Why?
|
Neoplasm Staging | 2 | 2008 | 11262 | 0.130 |
Why?
|
Algorithms | 4 | 2009 | 14201 | 0.120 |
Why?
|
Metabolome | 2 | 2014 | 1009 | 0.120 |
Why?
|
Child | 17 | 2016 | 80960 | 0.120 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2016 | 297 | 0.120 |
Why?
|
Male | 30 | 2024 | 365203 | 0.110 |
Why?
|
Glioma | 3 | 2012 | 3532 | 0.110 |
Why?
|
Gene Expression Regulation | 4 | 2016 | 11932 | 0.110 |
Why?
|
Tetrazolium Salts | 1 | 2013 | 92 | 0.110 |
Why?
|
Cerebellum | 2 | 2013 | 1522 | 0.110 |
Why?
|
Moyamoya Disease | 1 | 1997 | 274 | 0.110 |
Why?
|
Amino Acids | 2 | 2010 | 1716 | 0.110 |
Why?
|
Inositol | 2 | 2010 | 216 | 0.110 |
Why?
|
Motor Cortex | 2 | 2013 | 1014 | 0.110 |
Why?
|
Psychomotor Performance | 1 | 2002 | 1894 | 0.110 |
Why?
|
Oxidation-Reduction | 2 | 2013 | 2226 | 0.110 |
Why?
|
Aconitate Hydratase | 1 | 2013 | 17 | 0.110 |
Why?
|
Transcription Factors | 6 | 2024 | 12174 | 0.110 |
Why?
|
Neoplasms | 2 | 2013 | 22389 | 0.100 |
Why?
|
Physical Conditioning, Animal | 1 | 2016 | 363 | 0.100 |
Why?
|
Inappropriate ADH Syndrome | 1 | 2012 | 59 | 0.100 |
Why?
|
RNA, Messenger | 4 | 2009 | 12806 | 0.100 |
Why?
|
Mutation | 2 | 2014 | 30266 | 0.100 |
Why?
|
Child, Preschool | 11 | 2009 | 42683 | 0.100 |
Why?
|
Infant | 10 | 2009 | 36556 | 0.090 |
Why?
|
Attention | 1 | 2002 | 2423 | 0.090 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2013 | 690 | 0.090 |
Why?
|
Signal Transduction | 2 | 2014 | 23653 | 0.090 |
Why?
|
Analysis of Variance | 2 | 2010 | 6236 | 0.090 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2019 | 553 | 0.090 |
Why?
|
Bacterial Proteins | 1 | 2024 | 3840 | 0.090 |
Why?
|
Reference Values | 2 | 2012 | 4940 | 0.090 |
Why?
|
Microarray Analysis | 1 | 2013 | 755 | 0.090 |
Why?
|
Receptors, Glucagon | 1 | 2010 | 90 | 0.090 |
Why?
|
Adolescent | 12 | 2010 | 89244 | 0.090 |
Why?
|
Glutarates | 1 | 2012 | 243 | 0.090 |
Why?
|
Databases, Factual | 1 | 2006 | 8094 | 0.090 |
Why?
|
Disease Models, Animal | 5 | 2024 | 18354 | 0.090 |
Why?
|
Nerve Net | 1 | 2002 | 2359 | 0.080 |
Why?
|
PPAR delta | 1 | 2009 | 40 | 0.080 |
Why?
|
Equipment and Supplies | 1 | 2012 | 274 | 0.080 |
Why?
|
Adaptation, Physiological | 1 | 2016 | 1313 | 0.080 |
Why?
|
Central Nervous System Diseases | 1 | 1993 | 521 | 0.080 |
Why?
|
Random Allocation | 2 | 2010 | 2394 | 0.080 |
Why?
|
Phosphorus Isotopes | 1 | 2008 | 125 | 0.080 |
Why?
|
PPAR alpha | 1 | 2009 | 177 | 0.080 |
Why?
|
Fatty Acids | 2 | 2006 | 1812 | 0.070 |
Why?
|
Regression Analysis | 2 | 2008 | 6346 | 0.070 |
Why?
|
Glucose Transporter Type 4 | 1 | 2008 | 241 | 0.070 |
Why?
|
Astrocytoma | 1 | 2012 | 781 | 0.070 |
Why?
|
Muscular Atrophy | 1 | 2010 | 335 | 0.070 |
Why?
|
Mice, Inbred C57BL | 4 | 2024 | 22379 | 0.070 |
Why?
|
Chronic Disease | 2 | 2013 | 9384 | 0.070 |
Why?
|
Ischemia | 1 | 2016 | 1900 | 0.070 |
Why?
|
Models, Biological | 3 | 2008 | 9499 | 0.070 |
Why?
|
Prognosis | 4 | 2011 | 30046 | 0.070 |
Why?
|
Drug Resistance, Bacterial | 1 | 2014 | 1063 | 0.070 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2018 | 0.070 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2010 | 550 | 0.070 |
Why?
|
Logistic Models | 3 | 2011 | 13318 | 0.070 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2008 | 394 | 0.070 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7478 | 0.070 |
Why?
|
Drug Discovery | 1 | 2014 | 1068 | 0.070 |
Why?
|
Artificial Limbs | 1 | 2008 | 121 | 0.070 |
Why?
|
Thiazoles | 1 | 2013 | 1542 | 0.060 |
Why?
|
Blotting, Western | 1 | 2013 | 5033 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2002 | 5831 | 0.060 |
Why?
|
Reproducibility of Results | 3 | 2008 | 20245 | 0.060 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 797 | 0.060 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 958 | 0.060 |
Why?
|
Phantoms, Imaging | 2 | 2012 | 2533 | 0.060 |
Why?
|
In Situ Nick-End Labeling | 1 | 2005 | 612 | 0.060 |
Why?
|
Electron Transport | 1 | 2005 | 211 | 0.060 |
Why?
|
Gluconeogenesis | 1 | 2005 | 185 | 0.060 |
Why?
|
Glycolysis | 1 | 2008 | 838 | 0.060 |
Why?
|
Metabolomics | 1 | 2013 | 1675 | 0.060 |
Why?
|
Radiography | 2 | 2013 | 6991 | 0.060 |
Why?
|
Smith-Lemli-Opitz Syndrome | 1 | 2003 | 46 | 0.060 |
Why?
|
Transcription, Genetic | 2 | 2009 | 7609 | 0.050 |
Why?
|
Meningioma | 1 | 2012 | 1226 | 0.050 |
Why?
|
Recovery of Function | 1 | 2013 | 2990 | 0.050 |
Why?
|
Cold Temperature | 1 | 2006 | 791 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2009 | 1426 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2008 | 14752 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13510 | 0.050 |
Why?
|
Leukodystrophy, Globoid Cell | 1 | 2001 | 38 | 0.050 |
Why?
|
Phosphates | 1 | 2005 | 765 | 0.050 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2006 | 621 | 0.050 |
Why?
|
Prosthesis Design | 1 | 2008 | 2126 | 0.040 |
Why?
|
Models, Neurological | 1 | 2009 | 1782 | 0.040 |
Why?
|
Virulence Factors | 1 | 2024 | 502 | 0.040 |
Why?
|
Dominance, Cerebral | 1 | 2002 | 624 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2009 | 1891 | 0.040 |
Why?
|
Cluster Analysis | 1 | 2007 | 2732 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2005 | 2488 | 0.040 |
Why?
|
Information Storage and Retrieval | 1 | 2006 | 831 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2010 | 2893 | 0.040 |
Why?
|
Age Factors | 2 | 2010 | 18435 | 0.040 |
Why?
|
Diffusion | 1 | 2002 | 818 | 0.040 |
Why?
|
Creatine | 2 | 2004 | 427 | 0.040 |
Why?
|
Epilepsy | 2 | 2012 | 3326 | 0.040 |
Why?
|
Xanthine Oxidase | 1 | 2019 | 69 | 0.040 |
Why?
|
Female | 14 | 2012 | 397515 | 0.040 |
Why?
|
Lactates | 2 | 2000 | 401 | 0.040 |
Why?
|
Adult | 10 | 2012 | 223851 | 0.040 |
Why?
|
NADP | 1 | 2019 | 230 | 0.040 |
Why?
|
Acetylcysteine | 1 | 2019 | 262 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10115 | 0.040 |
Why?
|
Neural Pathways | 1 | 2009 | 3120 | 0.040 |
Why?
|
Wakefulness | 1 | 2005 | 1284 | 0.040 |
Why?
|
Hypoxia-Ischemia, Brain | 1 | 2001 | 359 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 2911 | 0.040 |
Why?
|
Virulence | 2 | 2014 | 1298 | 0.040 |
Why?
|
Computer Simulation | 1 | 2011 | 6291 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2002 | 1019 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 4939 | 0.030 |
Why?
|
Receptors, Estrogen | 1 | 2024 | 2252 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2007 | 5323 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2005 | 6232 | 0.030 |
Why?
|
Angiogenic Proteins | 1 | 2016 | 101 | 0.030 |
Why?
|
Disease Progression | 2 | 2004 | 13674 | 0.030 |
Why?
|
Immune Tolerance | 1 | 2024 | 2323 | 0.030 |
Why?
|
Parietal Lobe | 1 | 2000 | 866 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2012 | 6401 | 0.030 |
Why?
|
Case-Control Studies | 1 | 2012 | 22296 | 0.030 |
Why?
|
Young Adult | 3 | 2012 | 60131 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2019 | 1165 | 0.030 |
Why?
|
Obesity | 1 | 2016 | 13091 | 0.030 |
Why?
|
Gene Expression | 1 | 2006 | 7603 | 0.030 |
Why?
|
Drug Resistance, Multiple | 1 | 2014 | 255 | 0.030 |
Why?
|
Capillaries | 1 | 2016 | 756 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 1141 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2007 | 12562 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26395 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2016 | 874 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 859 | 0.020 |
Why?
|
Heart Arrest | 1 | 2001 | 1515 | 0.020 |
Why?
|
Middle Aged | 4 | 2012 | 223737 | 0.020 |
Why?
|
Extremities | 1 | 2016 | 870 | 0.020 |
Why?
|
Creatinine | 1 | 1996 | 1917 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2004 | 15471 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2016 | 1495 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2003 | 26428 | 0.020 |
Why?
|
Virus Cultivation | 1 | 2007 | 88 | 0.020 |
Why?
|
Time Factors | 2 | 2006 | 40261 | 0.020 |
Why?
|
Hemodynamics | 1 | 1997 | 4199 | 0.020 |
Why?
|
Rheology | 1 | 2008 | 348 | 0.020 |
Why?
|
Brain Mapping | 1 | 2002 | 6739 | 0.020 |
Why?
|
Central Nervous System | 1 | 1993 | 1346 | 0.020 |
Why?
|
Phosphorylation | 1 | 2016 | 8317 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2019 | 19023 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2002 | 9442 | 0.010 |
Why?
|
Hydrogen | 1 | 2003 | 171 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 1993 | 2660 | 0.010 |
Why?
|
Quinolines | 1 | 2007 | 772 | 0.010 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2007 | 1137 | 0.010 |
Why?
|
Cytokines | 1 | 2016 | 7453 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2007 | 65480 | 0.010 |
Why?
|
Phosphorylcholine | 1 | 2000 | 153 | 0.010 |
Why?
|
Twins, Monozygotic | 1 | 2001 | 472 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2003 | 1998 | 0.010 |
Why?
|
Gliosis | 1 | 2000 | 246 | 0.010 |
Why?
|
Basal Ganglia | 1 | 2001 | 555 | 0.010 |
Why?
|
Linear Models | 1 | 2008 | 5891 | 0.010 |
Why?
|
Cell Survival | 1 | 2007 | 5793 | 0.010 |
Why?
|
Resuscitation | 1 | 2001 | 679 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2001 | 1836 | 0.010 |
Why?
|
Brain Stem | 1 | 2001 | 862 | 0.010 |
Why?
|
Necrosis | 1 | 2000 | 1620 | 0.010 |
Why?
|
Thalamus | 1 | 2001 | 1049 | 0.010 |
Why?
|
Cholesterol | 1 | 2003 | 2913 | 0.010 |
Why?
|
Inflammation | 1 | 2006 | 10868 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2003 | 15951 | 0.000 |
Why?
|
Aged | 1 | 2012 | 171786 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2003 | 81903 | 0.000 |
Why?
|